GL Capital Management GP Limited Increases Stake in ZYLOXTB (02190) by 4.4 Million Shares, Holding 6.09%

Stock News11-19

Latest data from the Hong Kong Stock Exchange shows that on November 14, GL Capital Management GP Limited acquired an additional 4.4 million shares of ZYLOXTB (02190) at an average price of HK$24 per share, totaling HK$105.6 million. Following this purchase, GL Capital's total holdings in the company reached 20.5 million shares, representing a 6.09% stake.

Public records indicate that ZYLOXTB's current shareholders include prominent healthcare-focused investment firms such as Orbimed, Lake Bleu Capital, and AIHC Capital. The recent stake increase by GL Capital underscores market confidence in ZYLOXTB's operational stability and growth potential.

In recent years, ZYLOXTB has actively expanded its innovative product pipeline, accelerated the global rollout of its core products, and strengthened its international operations. The company stated that it remains committed to its mission of "Innovating for Life" by increasing R&D investments in medical technology to deliver high-quality, affordable medical device solutions to patients worldwide.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1104477849?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-19 12:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1104477849","market":"sh","top_or_hot":-1,"title":"GL Capital Management GP Limited Increases Stake in ZYLOXTB (02190) by 4.4 Million Shares, Holding 6.09%","media":"Stock News","content":"<p>Latest data from the Hong Kong Stock Exchange shows that on November 14, GL Capital Management GP Limited acquired an additional 4.4 million shares of ZYLOXTB (02190) at an average price of HK$24 per share, totaling HK$105.6 million. Following this purchase, GL Capital's total holdings in the company reached 20.5 million shares, representing a 6.09% stake.</p>\n<p>Public records indicate that ZYLOXTB's current shareholders include prominent healthcare-focused investment firms such as Orbimed, Lake Bleu Capital, and AIHC Capital. The recent stake increase by GL Capital underscores market confidence in ZYLOXTB's operational stability and growth potential.</p>\n<p>In recent years, ZYLOXTB has actively expanded its innovative product pipeline, accelerated the global rollout of its core products, and strengthened its international operations. The company stated that it remains committed to its mission of \"Innovating for Life\" by increasing R&D investments in medical technology to deliver high-quality, affordable medical device solutions to patients worldwide.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>GL Capital Management GP Limited Increases Stake in ZYLOXTB (02190) by 4.4 Million Shares, Holding 6.09%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGL Capital Management GP Limited Increases Stake in ZYLOXTB (02190) by 4.4 Million Shares, Holding 6.09%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-19 12:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Latest data from the Hong Kong Stock Exchange shows that on November 14, GL Capital Management GP Limited acquired an additional 4.4 million shares of ZYLOXTB (02190) at an average price of HK$24 per share, totaling HK$105.6 million. Following this purchase, GL Capital's total holdings in the company reached 20.5 million shares, representing a 6.09% stake.</p>\n<p>Public records indicate that ZYLOXTB's current shareholders include prominent healthcare-focused investment firms such as Orbimed, Lake Bleu Capital, and AIHC Capital. The recent stake increase by GL Capital underscores market confidence in ZYLOXTB's operational stability and growth potential.</p>\n<p>In recent years, ZYLOXTB has actively expanded its innovative product pipeline, accelerated the global rollout of its core products, and strengthened its international operations. The company stated that it remains committed to its mission of \"Innovating for Life\" by increasing R&D investments in medical technology to deliver high-quality, affordable medical device solutions to patients worldwide.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014005.SGD","symbol_name":"United Global Durable Equities Fund Acc SGD","start_time":0,"source_url":"","article_id":"1104477849","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1104477849","pubTimestamp":1763524822,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Latest data from the Hong Kong Stock Exchange shows that on November 14, GL Capital Management GP Limited acquired an additional 4.4 million shares of ZYLOXTB (02190) at an average price of HK$24 per...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","LU2491049909.HKD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (HKD) ACC","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU2491050071.SGD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (SGDHDG) ACC","BK4149":"建筑机械与重型卡车","LU1323610961.USD":"UBS (LUX) EQUITY SICAV - LONG TERM THEMES (USD) \"P\" (USD) ACC","LU2491050154.USD":"WELLINGTON SUSTAINABLE OUTCOMES \"A\" (USD) ACC","BK1100":"医疗保健设备","02190":"归创通桥","LU1878469433.USD":"THREADNEEDLE (LUX) - AMERICAN SMALLER COMPANIES \"A\" (USD) ACC","BK4585":"ETF&股票定投概念","BK1587":"次新股","BK4162":"人寿与健康保险","BK1574":"生物医药B类股","GL":"Globe Life Inc.","GP":"GreenPower Motor Company Inc.","BK1583":"高瓴概念","BK4559":"巴菲特持仓","BK4588":"碎股"},"translate_title":"GL Capital Management GP Limited增持ZYLOXTB(02190)440万股持股6.09%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GL":1,"GP":1,"02190":1},"content_text":"Latest data from the Hong Kong Stock Exchange shows that on November 14, GL Capital Management GP Limited acquired an additional 4.4 million shares of ZYLOXTB (02190) at an average price of HK$24 per share, totaling HK$105.6 million. Following this purchase, GL Capital's total holdings in the company reached 20.5 million shares, representing a 6.09% stake.\nPublic records indicate that ZYLOXTB's current shareholders include prominent healthcare-focused investment firms such as Orbimed, Lake Bleu Capital, and AIHC Capital. The recent stake increase by GL Capital underscores market confidence in ZYLOXTB's operational stability and growth potential.\nIn recent years, ZYLOXTB has actively expanded its innovative product pipeline, accelerated the global rollout of its core products, and strengthened its international operations. The company stated that it remains committed to its mission of \"Innovating for Life\" by increasing R&D investments in medical technology to deliver high-quality, affordable medical device solutions to patients worldwide.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1104477849","isCrawlerRequest":true}